These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 16981954)
1. Laparoscopic scar: a mimicker of Sister Mary Joseph's nodule on positron emission tomography/CT. Setty B; Blake MA; Holalkere NS; Blaszkowsky LS; Fischman A Australas Radiol; 2006 Oct; 50(5):507-9. PubMed ID: 16981954 [TBL] [Abstract][Full Text] [Related]
2. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
3. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ; Zhang YX; Wei H; Jia Q Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544 [TBL] [Abstract][Full Text] [Related]
4. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748 [TBL] [Abstract][Full Text] [Related]
5. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Metser U; Even-Sapir E Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153 [TBL] [Abstract][Full Text] [Related]
6. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
8. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study. Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666 [TBL] [Abstract][Full Text] [Related]
9. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492 [TBL] [Abstract][Full Text] [Related]
10. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575 [TBL] [Abstract][Full Text] [Related]
12. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y; Cullum I; Illidge TM; Ell PJ J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153 [TBL] [Abstract][Full Text] [Related]
13. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256 [TBL] [Abstract][Full Text] [Related]
14. F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas. Suga K; Yasuhiko K; Hiyama A; Takeda K; Matsunaga N Clin Nucl Med; 2009 Sep; 34(9):589-93. PubMed ID: 19692819 [TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Potter KC; Husband JE; Houghton SL; Thomas K; Brown G Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420 [TBL] [Abstract][Full Text] [Related]